MDM2 and endometrioid tumor: We did not, however, ascertain whether the combination of MDM2 and TP53 Arg72Pro was associated with high-grade or non-endometrioid tumors as the overall number of these cases (G3, 10 cases; non-endometrioid, 13 cases) was small.